HOUSTON – Almost half of stroke survivors can experience spasticity, meaning their muscles get tighter and tighter until they lose the ability to move. RELATED: How one program is helping brain trauma ...

Background OnabotulinumtoxinA has demonstrated significant benefit in adult focal spasticity. This study reviews the injection patterns (i.e., muscle distribution, dosing) of onabotulinumtoxinA for ...

Expert Rev Neurother. 2009;9(12):1713-1725. The first patients with squint were successfully treated in 1977 [17] and since then botulinum toxin type A delivered by local injection has been used in ...

Add Yahoo as a preferred source to see more of our stories on Google. When you buy through links on our articles, Future and its syndication partners may earn a commission. Credit: Getty Images Beauty ...

Allergan plc (NYSE: AGN), a leading global pharmaceutical company today announced that the U.S. Food and Drug Administration (FDA) has accepted the company's resubmission of its Supplemental Biologics ...

NORTH CHICAGO, Ill., Oct. 6, 2025 /PRNewswire/ -- AbbVie (ABBV) today announced positive topline results from the Phase 2 ELATE trial evaluating the safety and efficacy of onabotulinumtoxinA (BOTOX®) ...

Botox (onabotulinumtoxinA) is a brand-name injectable drug for medical and aesthetic treatments. Aftercare instructions typically aim to help minimize your risk of bruising and prevent Botox from ...

Botox, while generally safe, carries a risk of neurological side effects, such as drooping eyelids, dizziness, and headache. More serious complications, including nerve damage, may occur in rare cases ...